From: VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
Clinicopathologic features | No. | VEGFR2 expression | VTN expression | ||||||
---|---|---|---|---|---|---|---|---|---|
High (No.) | Low (No.) | χ2 | P value | High (No.) | Low (No.) | χ2 | P value | ||
Gender | 96 | 60 | 92 | 64 | |||||
Men | 110 | 65 | 45 | 0.944 | 0.331 | 62 | 48 | 1.051 | 0.305 |
Women | 46 | 31 | 15 | 30 | 16 | ||||
Age (years) | |||||||||
<65 | 90 | 53 | 37 | 0.631 | 0.427 | 51 | 39 | 0.468 | 0.494 |
≥65 | 66 | 43 | 23 | 41 | 25 | ||||
Tumor size (cm) | |||||||||
<5 | 101 | 58 | 43 | 2.047 | 0.153 | 55 | 46 | 2.418 | 0.12 |
≥5 | 55 | 38 | 17 | 37 | 18 | ||||
Lauren type | |||||||||
Intestinal type | 91 | 55 | 36 | 0.111 | 0.739 | 53 | 38 | 0.048 | 0.826 |
Diffuse type | 65 | 41 | 24 | 39 | 26 | ||||
Degree of differentiation | |||||||||
Highly | 46 | 28 | 18 | 0.012 | 0.912 | 26 | 20 | 0.162 | 0.687 |
Moderately and Poorly | 110 | 68 | 42 | 66 | 44 | ||||
Depth of invasion | |||||||||
T1, T2 | 61 | 28 | 33 | 10.348 | <0.001** | 27 | 34 | 8.961 | <0.003** |
T3, T4 | 95 | 68 | 27 | 65 | 30 | ||||
Lymphonodus metastasis | |||||||||
N0, N1 | 50 | 22 | 28 | 9.563 | <0.002** | 21 | 29 | 8.763 | <0.003** |
N2, N3 | 106 | 74 | 32 | 71 | 35 | ||||
AJCC stage | |||||||||
I, II | 51 | 18 | 33 | 22.05 | <0.001** | 18 | 33 | 17.561 | <0.001** |
III, IV | 105 | 78 | 27 | 74 | 31 |